Current prophylactic medications for migraine and their potential mechanisms of action

85Citations
Citations of this article
223Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A relatively high number of different medications is currently used for migraine prevention in clinical practice. Although these compounds were initially developed for other indications and differ in their mechanisms of action, some general themes can be identified from the mechanisms at play. Efficacious preventive drugs seem to either suppress excitatory nervous signaling via sodium and/or calcium receptors, facilitate GABAergic inhibition, reduce neuronal sensitization, block cortical spreading depression and/or reduce circulating levels of CGRP. We here review such mechanisms for the different compounds.

Cite

CITATION STYLE

APA

Sprenger, T., Viana, M., & Tassorelli, C. (2018). Current prophylactic medications for migraine and their potential mechanisms of action. Neurotherapeutics, 15(2), 313–323. https://doi.org/10.1007/s13311-018-0621-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free